Optimizing Treatment De‐Escalation in Head and Neck Cancer: Current and Future Perspectives

ανά Rosenberg, Ari J., Vokes, Everett E.
Τόπος έκδοσης Oncologist (2020)

MET as a target for treatment of chest tumours

ανά Cipriani, Nicole A., Abidoye, Oyewale O., Vokes, Everett E., Salgia, Ravi
Έκδοση 2008

Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non–Small-Cell Lung Cancer

ανά Edelman, Martin J., Hodgson, Lydia, Wang, Xiaofei, Kratzke, Robert A., Vokes, Everett E.
Έκδοση 2012

Crizotinib (PF02341066) as a ALK /MET inhibitor— Special Emphasis as a Therapeutic Drug Against Lung Cancer

ανά Nwizu, Tobenna, Kanteti, Rajani, Kawada, Ichiro, Rolle, Cleo, Vokes, Everett E., Salgia, Ravi
Τόπος έκδοσης Drugs Future (2011)

Adjuvant treatment for high‐risk salivary gland malignancies and prognostic stratification based on a 20‐year single institution experience

ανά Onderdonk, Benjamin E., Vokes, Everett E., Gwede, Michael, Blair, Elizabeth, Agrawal, Nishant, Haraf, Daniel J.
Τόπος έκδοσης Health Sci Rep (2020)

Factors Associated with Clinical Benefit from Epidermal Growth Factor Receptor Inhibitors in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck

ανά Wyssam Cohen, Ezra Eddy, Halpern, Anna B., Kasza, Kristen, Kocherginsky, Masha, Williams, Rosalyn, Vokes, Everett E.
Έκδοση 2009

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

ανά Rudin, Charles M., Salgia, Ravi, Wang, Xiaofei, Hodgson, Lydia D., Masters, Gregory A., Green, Mark, Vokes, Everett E.
Έκδοση 2008

Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer

ανά Kawada, Ichiro, Hasina, Rifat, Arif, Qudsia, Mueller, Jeffrey, Smithberger, Erin, Husain, Aliya N., Vokes, Everett E., Salgia, Ravi
Τόπος έκδοσης Cancer Res (2013)

Heuristic value-based framework for lung cancer decision-making

ανά Mambetsariev, Isa, Pharaon, Rebecca, Nam, Arin, Knopf, Kevin, Djulbegovic, Benjamin, Villaflor, Victoria M., Vokes, Everett E., Salgia, Ravi
Τόπος έκδοσης Oncotarget (2018)

Efficacy of the Multi-Kinase Inhibitor Enzastaurin is Dependent on Cellular Signaling Context

ανά Kuo, Wen-Liang, Liu, Jing, Mauceri, Helena, Vokes, Everett E, Weichselbaum, Ralph, Rosner, Marsha Rich, Cohen, Ezra Eddy Wyssam
Έκδοση 2010

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Ca...

ανά Govindan, Ramaswamy, Bogart, Jeffrey, Stinchcombe, Thomas, Wang, Xiaofei, Hodgson, Lydia, Kratzke, Robert, Garst, Jennifer, Brotherton, Timothy, Vokes, Everett E.
Έκδοση 2011

Phase II study of dasatinib in patients with previously treated malignant mesothelioma (Cancer and Leukemia Group B 30601): a brief report

ανά Dudek, Arkadiusz Z., Pang, Herbert, Kratzke, Robert A., Otterson, Gregory A., Hodgson, Lydia, Vokes, Everett E., Kindler, Hedy L.
Έκδοση 2012

Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy

ανά Maggiore, Ronald J., Curran, Emily K., Witt, Mary Ellyn, Haraf, Daniel J., Vokes, Everett E., Cohen, Ezra E.W.
Τόπος έκδοσης J Geriatr Oncol (2013)

The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium

ανά Nimeiri, Halla S., Singh, Deepti A., Kasza, Kristen, Taber, David A., Ansari, Rafat H., Vokes, Everett E., Kindler, Hedy L.
Τόπος έκδοσης Invest New Drugs (2009)

Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B trial 9430

ανά Stinchcombe, Thomas E., Mauer, Ann M., Hodgson, Lydia D., Herndon, James E., Lynch, Thomas J., Green, Mark. R., Vokes, Everett E.
Έκδοση 2008

A Phase II Study of Dasatinib in Patients with Chemo-sensitive Relapsed Small Cell Lung Cancer (CALGB 30602)

ανά Miller, Antonius A., Pang, Herbert, Hodgson, Lydia, Ramnath, Nithya, Otterson, Gregory A., Kelley, Michael J., Kratzke, Robert A., Vokes, Everett E.
Έκδοση 2010

Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study

ανά Ready, Neal E., Dudek, Arkadiusz Z., Pang, Herbert H., Hodgson, Lydia D., Graziano, Stephen L., Green, Mark R., Vokes, Everett E.
Έκδοση 2011

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer

ανά Kanteti, Rajani, El-Hashani, Essam, Dhanasingh, Immanuel, Tretiakova, Maria, Husain, Aliya N, Sharma, Sherven, Sharma, Jay, Vokes, Everett E, Salgia, Ravi
Έκδοση 2014

Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy d...

ανά Salama, Joseph K., Pang, Herbert, Bogart, Jeffery A., Blackstock, A. William, Urbanic, James J., Hodgson, Lydia, Crawford, Jeffery, Vokes, Everett E.
Έκδοση 2013

Integrated Genomic Analysis Suggests MLL3 is a Novel Candidate Susceptibility Gene for Familial Nasopharyngeal Carcinoma

ανά Sasaki, Mark M, Skol, Andrew D, Bao, Riyue, Rhodes, Lindsay V, Chambers, Rachelle, Vokes, Everett E, Cohen, Ezra EW, Onel, Kenan
Τόπος έκδοσης Cancer Epidemiol Biomarkers Prev (2015)